James C. Gale, Director at INDEVUS PHARMACEUTICALS INC (IDEV), sold 258,011 shares at $7.35 ($1.9M) on 2007-06-05, disclosed to the SEC on 2007-06-07.
Open-market sale of $1.9M IDEV by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.35 | 3,750 | $28K | 1.5% |
| 2 | $7.35 | 15,760 | $116K | 6.1% |
| 3 | $7.35 | 16,671 | $123K | 6.5% |
| 4 | $7.35 | 37,563 | $276K | 14.6% |
| 5 | $7.35 | 49,507 | $364K | 19.2% |
| 6 | $7.35 | 76,077 |
| $559K |
| 29.5% |
| 7 | $7.36 | 774 | $6K | 0.3% |
| 8 | $7.36 | 3,253 | $24K | 1.3% |
| 9 | $7.36 | 3,441 | $25K | 1.3% |
| 10 | $7.36 | 7,763 | $57K | 3.0% |
| 11 | $7.36 | 10,218 | $75K | 4.0% |
| 12 | $7.36 | 15,702 | $116K | 6.1% |
| 13 | $7.36 | 17,532 | $129K | 6.8% |
| Total | $7.35 avg | 258,011 | $1.9M | 100% |
| Filing → |
| TLGT | BUY | 2017-11-13 | $57K | — | Filing → |
| TLGT | BUY | 2016-03-14 | $74K | — | Filing → |
| IG | BUY | 2015-05-01 | $151K | — | Filing → |